1. Home
  2. XHR vs SUPN Comparison

XHR vs SUPN Comparison

Compare XHR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XHR
  • SUPN
  • Stock Information
  • Founded
  • XHR 2007
  • SUPN 2005
  • Country
  • XHR United States
  • SUPN United States
  • Employees
  • XHR N/A
  • SUPN N/A
  • Industry
  • XHR Real Estate Investment Trusts
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • XHR Real Estate
  • SUPN Health Care
  • Exchange
  • XHR Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • XHR 1.5B
  • SUPN 1.7B
  • IPO Year
  • XHR N/A
  • SUPN 2012
  • Fundamental
  • Price
  • XHR $11.80
  • SUPN $32.82
  • Analyst Decision
  • XHR Buy
  • SUPN Hold
  • Analyst Count
  • XHR 5
  • SUPN 2
  • Target Price
  • XHR $17.10
  • SUPN $36.00
  • AVG Volume (30 Days)
  • XHR 966.9K
  • SUPN 634.8K
  • Earning Date
  • XHR 05-02-2025
  • SUPN 05-07-2025
  • Dividend Yield
  • XHR 4.76%
  • SUPN N/A
  • EPS Growth
  • XHR N/A
  • SUPN 6500.00
  • EPS
  • XHR 0.15
  • SUPN 1.32
  • Revenue
  • XHR $1,039,047,000.00
  • SUPN $661,817,000.00
  • Revenue This Year
  • XHR $5.48
  • SUPN N/A
  • Revenue Next Year
  • XHR $3.74
  • SUPN $9.32
  • P/E Ratio
  • XHR $78.47
  • SUPN $24.50
  • Revenue Growth
  • XHR 1.33
  • SUPN 8.94
  • 52 Week Low
  • XHR $11.43
  • SUPN $25.53
  • 52 Week High
  • XHR $16.50
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • XHR 30.69
  • SUPN 49.41
  • Support Level
  • XHR $11.43
  • SUPN $31.74
  • Resistance Level
  • XHR $12.81
  • SUPN $32.87
  • Average True Range (ATR)
  • XHR 0.34
  • SUPN 1.00
  • MACD
  • XHR -0.03
  • SUPN 0.23
  • Stochastic Oscillator
  • XHR 23.25
  • SUPN 71.76

About XHR Xenia Hotels & Resorts Inc.

Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The room segment contributes to the vast majority of the firm's total revenue. The firm's customer groups include transient business, group business, and contract business.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: